Franklin Resources Inc Clovis Oncology, Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$11.63 - $32.67 $20.5 Million - $57.6 Million	-1,761,885 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $14.5 Million - $24.5 Million	-494,638 Reduced 21.92%	1,761,885 $51.7 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $9.8 Million - $14.5 Million	-233,016 Reduced 9.36%	2,256,523 $103 Million
Q1 2018 May 10, 2018	SELL	$50.12 - $67.72 $7.26 Million - $9.81 Million	-144,862 Reduced 5.5%	2,489,539 $131 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $18.4 Million - $27 Million	318,931 Added 13.77%	2,634,401 $179 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $156 Million - $196 Million	2,315,470	2,315,470 $191 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.